Tomas Jan Heyman
Direktor/Vorstandsmitglied bei XILIO THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Tomas Jan Heyman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AKERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 09.06.2020 | - |
Independent Dir/Board Member | 09.06.2020 | - | |
OPTINOSE, INC. | Direktor/Vorstandsmitglied | 01.12.2020 | - |
Independent Dir/Board Member | 01.12.2020 | - | |
INVIVYD, INC. | Direktor/Vorstandsmitglied | 01.06.2021 | - |
Independent Dir/Board Member | 01.06.2021 | - | |
LEGEND BIOTECH CORPORATION | Direktor/Vorstandsmitglied | 02.08.2022 | - |
Independent Dir/Board Member | 02.08.2022 | - | |
XILIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.09.2022 | - |
Independent Dir/Board Member | 15.09.2022 | - | |
EXELIXIS, INC. | Direktor/Vorstandsmitglied | 31.05.2023 | - |
Independent Dir/Board Member | 31.05.2023 | - | |
Interlaken Therapeutics, Inc. | Vorstandsvorsitzender | - | - |
Interuniversitair Micro-Electronica Centrum VZW
Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Direktor/Vorstandsmitglied | 27.04.2012 | - |
Karriereverlauf von Tomas Jan Heyman
Ehemalige bekannte Positionen von Tomas Jan Heyman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Vorsitzender | 07.03.2023 | 16.05.2024 |
░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░░ ░ ░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Tomas Jan Heyman
Katholieke Universiteit Leuven | Graduate Degree |
University of Antwerp | Graduate Degree |
Statistik
International
Vereinigte Staaten | 13 |
Belgien | 5 |
Niederlande | 2 |
Operativ
Director/Board Member | 10 |
Independent Dir/Board Member | 6 |
Chairman | 2 |
Sektoral
Health Technology | 11 |
Commercial Services | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 8 |
---|---|
JOHNSON & JOHNSON | Health Technology |
EXELIXIS, INC. | Health Technology |
OPTINOSE, INC. | Health Technology |
CVRX, INC. | Health Technology |
LEGEND BIOTECH CORPORATION | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
AKERO THERAPEUTICS, INC. | Health Technology |
INVIVYD, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Commercial Services |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
International Biomedical Research Alliance
International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | Commercial Services |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
Ortho Pharmaceutical Corp. | |
Interuniversitair Micro-Electronica Centrum VZW
Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Commercial Services |
Interlaken Therapeutics, Inc. |
- Börse
- Insiders
- Tomas Jan Heyman
- Erfahrung